In re Evoqua Water Technologies Corp. Securities Litigation
|Court:||United States District Court of the Southern District of New York|
|Class Period:||11/06/2017 - 10/30/2018|
|Case Contacts:||Jeremy P. Robinson, Jai K. Chandrasekhar|
This is a federal securities class action on behalf of a class (the “Class”) consisting of all persons other than Defendants who purchased or otherwise acquired the securities of Evoqua Water Technologies Corp. (“Evoqua” or the “Company”) on the open market between November 6, 2017 and October 30, 2018, both dates inclusive (the “Class Period”), seeking to recover compensable damages caused by Defendants’ violations of the Securities Act of 1933 and the Securities Exchange Act of 1934. The Court appointed the Louisiana Sheriffs’ Pension and Relief Fund and the City of Omaha Police and Fire Retirement System as Lead Plaintiffs and approved their selection of BLB&G as co-lead counsel in January 2019. Lead Plaintiffs filed a consolidated complaint in March 2019.
Evoqua provides water-treatment services, systems, and technologies. Plaintiffs allege that in the registration statement and prospectus for Evoqua’s initial public offering at the start of the Class Period and in other statements throughout the Class Period, Defendants made materially false and misleading representations and omissions regarding the Company’s business and operations. Specifically, Defendants made false and misleading statements about Evoqua’s numerous purportedly successful acquisitions and purportedly effective salesforce, while failing to disclose that (i) Evoqua failed to successfully integrate its prior acquisitions; (ii) Evoqua laid off many of its most experienced and capable sales personnel, significantly harming its ability to make sales; and (iii) Evoqua improperly recognized revenue on products that were subject to broad rights of return, had not been ordered by customers, or had not even been manufactured.
On October 30, 2018, Evoqua announced its preliminary financial results for the fourth quarter and fiscal year ended September 30, 2018, which fell below the Company’s and analyst’s expectations. Evoqua stated that the shortfalls were “primarily due to acquisition system integration issues, supply chain disruptions influenced by tariffs and an extended delay on a large aquatics project.” On this news, which revealed the falsity of Defendants’ prior statements about Evoqua’s acquisitions, sales force, and revenue, Evoqua’s stock price fell $4.78 per share, or 34.64%, to close at $9.02 on October 30, 2018, thereby causing significant losses and damages to Plaintiffs and other Class members.
Defendants filed a motion to dismiss the action in June 2019, and the motion was fully briefed in October 2019.
Other Cases of Interest
Adeptus Health Inc.
Eastern District of Texas Jeremy P. Robinson, Abe Alexander
Northern District of California Jeroen van Kwawegen, Jeremy P. Robinson, Rebecca E. Boon
Western District of Pennsylvania Salvatore J. Graziano, Adam H. Wierzbowski, Jai K. Chandrasekhar, Brenna Nelinson, Alexander T. Payne
Southern District of New York Hannah Ross, Jai K. Chandrasekhar
Facebook, Inc. (IPO)
Southern District of New York Salvatore J. Graziano, John Rizio-Hamilton, Adam H. Wierzbowski, Jai K. Chandrasekhar
Spectrum Brands Holdings, Inc.
Western District of Wisconsin Avi Josefson, Katherine M. Sinderson, Jai K. Chandrasekhar, Matthew Traylor
Facebook, Inc. (Securities)
Northern District of California John C. Browne, Jeremy P. Robinson, Kate Aufses
Opko Health, Inc.
Southern District of Florida John Rizio-Hamilton, Jai K. Chandrasekhar, Adam Hollander, Brenna Nelinson, R. Ryan Dykhouse
Allergan, Inc. (Proxy Violation)
Central District of California Mark Lebovitch, Jeremy P. Robinson, Michael D. Blatchley, Richard D. Gluck, Edward G. Timlin